Kirkland Advises J.P. Morgan Private Capital on Close of Inaugural Biotechnology Venture Fund Over $500M
June 28, 2024
June 28, 2024
CHICAGO, Illinois, June 28 -- Kirkland and Ellis, a law firm, issued the following news release:
Kirkland advised J.P. Morgan Private Capital on the final closing of its inaugural biotechnology venture capital fund, 270 Life Sciences Private Capital Fund I.
The fund closed above its $500 million target, attracting strong support from investors, including institutional allocators, strategic corporate partners, family offices and high net worth individuals across North Am . . .
Kirkland advised J.P. Morgan Private Capital on the final closing of its inaugural biotechnology venture capital fund, 270 Life Sciences Private Capital Fund I.
The fund closed above its $500 million target, attracting strong support from investors, including institutional allocators, strategic corporate partners, family offices and high net worth individuals across North Am . . .